What have you always wondered about the economy? Tell Us

Drugmakers of insulin accused of price fixing

Reema Khrais Jan 31, 2017
HTML EMBED:
COPY

Drugmakers of insulin accused of price fixing

Reema Khrais Jan 31, 2017
HTML EMBED:
COPY

Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using expired insulin or starving themselves to control their blood sugar. The drug makers say the allegations have no merit. 

Click the above audio player to hear the full story. 

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.